Myeloid cell IL-10 production in response to Leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 367-378

  Nandan, Devki ^a   De Oliveira, Carolina Camargo ^a   Moeenrezakhanlou, Alireza ^a   Lopez, Martin ^a   Silverman, Judith M ^a   Subek, Jennifer ^a   Reiner, Neil E ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B BETA; SERINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEISHMANIA DONOVANI; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION;

ANIMALS; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOWN-REGULATION; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTERLEUKIN-10; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; MICE, INBRED BALB C; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84855387052     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100076     Document Type: Article

References (62)

1. Gueirard, P., A. Laplante, C. Rondeau, G. Milon, and M. Desjardins. 2008. Trafficking of Leishmania donovani promastigotes in non-lytic compartments in neutrophils enables the subsequent transfer of parasites to macrophages. Cell. Microbiol. 10: 100-111. (Pubitemid 350239059)
2. Peters, N. C., and D. L. Sacks. 2009. The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis. Cell. Microbiol. 11: 1290-1296.
3. Reiner, N. E. 1994. Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection. Immunol. Today 15: 374-381. (Pubitemid 24246911)
4. Nandan, D., and N. E. Reiner. 2005. Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. Clin. Immunol. 114: 266-277. (Pubitemid 40255132)
5. Olivier, M., D. J. Gregory, and G. Forget. 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 18: 293-305. (Pubitemid 40548295)
6. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183: 515-526. (Pubitemid 26059515)
7. Weinheber, N., M. Wolfram, D. Harbecke, and T. Aebischer. 1998. Phagocytosis of Leishmania mexicana amastigotes by macrophages leads to a sustained suppression of IL-12 production. Eur. J. Immunol. 28: 2467-2477. (Pubitemid 28362721)
8. Barral-Netto, M., A. Barral, C. E. Brownell, Y. A. W. Skeiky, L. R. Ellingsworth, D. R. Twardzik, and S. G. Reed. 1992. Transforming growth factor-β in leishmanial infection: a parasite escape mechanism. Science 257: 545-548.
9. Gasim, S., A. M. Elhassan, E. A. Khalil, A. Ismail, A. M. Kadaru, A. Kharazmi, and T. G. Theander. 1998. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis. Clin. Exp. Immunol. 111: 64-69. (Pubitemid 28062778)
10. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194: 1497-1506. (Pubitemid 33081524)
11. Awasthi, A., R. K. Mathur, and B. Saha. 2004. Immune response to Leishmania infection. Indian J. Med. Res. 119: 238-258. (Pubitemid 39076953)
12. Lang, R. 2005. Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection. Immunobiology 210: 63-76. (Pubitemid 41025147)
13. Varin, A., S. Mukhopadhyay, G. Herbein, and S. Gordon. 2010. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115: 353-362.
14. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-γ-activated macrophages. J. Immunol. 148: 1792-1796.
15. Teixeira, M. J., C. R. Teixeira, B. B. Andrade, M. Barral-Netto, and A. Barral. 2006. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol. 22: 32-40. (Pubitemid 43017202)
16. Murray, H. W., C. M. Lu, S. Mauze, S. Freeman, A. L. Moreira, G. Kaplan, and R. L. Coffman. 2002. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 70: 6284-6293. (Pubitemid 35192720)
17. Yang, Z., D. M. Mosser, and X. Zhang. 2007. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J. Immunol. 178: 1077-1085. (Pubitemid 46095181)
18. Mathur, R. K., A. Awasthi, P. Wadhone, B. Ramanamurthy, and B. Saha. 2004. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat. Med. 10: 540-544. (Pubitemid 38667915)
19. Chandra, D., and S. Naik. 2008. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin. Exp. Immunol. 154: 224-234.
20. Privé, C., and A. Descoteaux. 2000. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur. J. Immunol. 30: 2235-2244. (Pubitemid 30655763)
21. Nandan, D., R. Lo, and N. E. Reiner. 1999. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect. Immun. 67: 4055-4063. (Pubitemid 29357028)
22. Okkenhaug, K., and B. Vanhaesebroeck. 2003. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3: 317-330. (Pubitemid 37328684)
23. Ruhland, A., N. Leal, and P. E. Kima. 2007. Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis. Cell. Microbiol. 9: 84-96. (Pubitemid 44896837)
24. Ruhland, A., and P. E. Kima. 2009. Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp. Parasitol. 122: 28-36.
25. Fukui, Y., S. Ihara, and S. Nagata. 1998. Downstream of phosphatidylinositol-3 kinase, a multifunctional signaling molecule, and its regulation in cell responses. J. Biochem. 124: 1-7. (Pubitemid 28379466)
26. Vanhaesebroeck, B., and D. R. Alessi. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346: 561-576. (Pubitemid 30171014)
27. Cross, D. A., D. R. Alessi, P. Cohen, M. Andjelkovich, and B. A. Hemmings. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789. (Pubitemid 26004411)
28. Grimes, C. A., and R. S. Jope. 2001. CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium. J. Neurochem. 78: 1219-1232. (Pubitemid 32899754)
29. Platzer, C., E. Fritsch, T. Elsner, M. H. Lehmann, H. D. Volk, and S. Prösch. 1999. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur. J. Immunol. 29: 3098-3104. (Pubitemid 29484199)
30. Guha, M., and N. Mackman. 2002. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277: 32124-32132. (Pubitemid 34969025)
31. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6: 777-784. (Pubitemid 43090463)
32. Pengal, R. A., L. P. Ganesan, G. Wei, H. Fang, M. C. Ostrowski, and S. Tridandapani. 2006. Lipopolysaccharide-induced production of interleukin-10 is promoted by the serine/threonine kinase Akt. Mol. Immunol. 43: 1557-1564.
33. Giraudo, E., L. Primo, E. Audero, H. P. Gerber, P. Koolwijk, S. Soker, M. Klagsbrun, N. Ferrara, and F. Bussolino. 1998. Tumor necrosis factor-α regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J. Biol. Chem. 273: 22128-22135. (Pubitemid 28405397)
34. Moeenrezakhanlou, A., D. Nandan, L. Shephard, and N. E. Reiner. 2007. 1α,25-Dihydroxycholecalciferol activates binding of CREB to a CRE site in the CD14 promoter and drives promoter activity in a phosphatidylinositol-3 kinase-dependent manner. J. Leukoc. Biol. 81: 1311-1321. (Pubitemid 46702051)
35. Hanada, M., J. Feng, and B. A. Hemmings. 2004. Structure, regulation and function of PKB/AKT: a major therapeutic target. Biochim. Biophys. Acta 1697: 3-16. (Pubitemid 38326757)
36. Calleja, V., M. Laguerre, P. J. Parker, and B. Larijani. 2009. Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 7: e17.
37. Späth, G. F., and S. M. Beverley. 2001. A lipophosphoglycan- independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp. Parasitol. 99: 97-103. (Pubitemid 34038221)
38. Forde, J. E., and T. C. Dale. 2007. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell. Mol. Life Sci. 64: 1930-1944. (Pubitemid 47094432)
39. Johannessen, M., M. P. Delghandi, and U. Moens. 2004. What turns CREB on? Cell. Signal. 16: 1211-1227. (Pubitemid 39165450)
40. Bullock, B. P., and J. F. Habener. 1998. Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge. Biochemistry 37: 3795-3809. (Pubitemid 28162935)
41. 129 is required for the cAMP-mediated control of gene expression: a role for glycogen synthase kinase-3 in the control of gene expression. J. Biol. Chem. 269: 32187-32193.
42. Nandan, D., K. L. Knutson, R. Lo, and N. E. Reiner. 2000. Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis. J. Leukoc. Biol. 67: 464-470.
43. Bliska, J. B., J. E. Galán, and S. Falkow. 1993. Signal transduction in the mammalian cell during bacterial attachment and entry. Cell 73: 903-920. (Pubitemid 23165607)
44. Sibley, L. D., and J. L. Krahenbuhl. 1987. Mycobacterium leprae-burdened macrophages are refractory to activation by γ interferon. Infect. Immun. 55: 446-450. (Pubitemid 17004126)
45. Sibley, L. D., L. B. Adams, and J. L. Krahenbuhl. 1990. Inhibition of interferon-γ-mediated activation in mouse macrophages treated with lipoarabinomannan. Clin. Exp. Immunol. 80: 141-148. (Pubitemid 20113418)
46. Kaye, P. M., M. Sims, and M. Feldmann. 1986. Regulation of macrophage accessory cell activity by mycobacteria, II: In vitro inhibition of Ia expression by Mycobacterium microti. Clin. Exp. Immunol. 64: 28-34. (Pubitemid 16103067)
47. Baldwin, G. C., J. Fleischmann, Y. Chung, Y. Koyanagi, I. S. Y. Chen, and D. W. Golde. 1990. Human immunodeficiency virus causes mononuclear phagocyte dysfunction. Proc. Natl. Acad. Sci. USA 87: 3933-3937.
48. Coggeshall, K. M. 1999. Negative signaling in health and disease. Immunol. Res. 19: 47-64. (Pubitemid 29248712)
49. Reiner, N. E., W. Ng, C. B. Wilson, W. R. McMaster, and S. K. Burchett. 1990. Modulation of in vitro monocyte cytokine responses to Leishmania donovani: interferon-γ prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-α and interleukin 1. J. Clin. Invest. 85: 1914-1924. (Pubitemid 20192968)
50. Murphy, M. L., U. Wille, E. N. Villegas, C. A. Hunter, and J. P. Farrell. 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 31: 2848-2856. (Pubitemid 32994535)
51. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13: 2905-2927.
52. Brazil, D. P., Z. Z. Yang, and B. A. Hemmings. 2004. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 29: 233-242. (Pubitemid 38591317)
53. Alessi, D. R., and P. Cohen. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev. 8: 55-62. (Pubitemid 28122141)
54. Cho, H., J. L. Thorvaldsen, Q. Chu, F. Feng, and M. J. Birnbaum. 2001. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276: 38349-38352.
55. George, S., J. J. Rochford, C. Wolfrum, S. L. Gray, S. Schinner, J. C. Wilson, M. A. Soos, P. R. Murgatroyd, R. M. Williams, C. L. Acerini, et al. 2004. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304: 1325-1328. (Pubitemid 38697429)
56. Easton, R. M., H. Cho, K. Roovers, D. W. Shineman, M. Mizrahi, M. S. Forman, V. M. Lee, M. Szabolcs, R. de Jong, T. Oltersdorf, et al. 2005. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol. 25: 1869-1878. (Pubitemid 40280150)
57. Figueroa, C., S. Tarras, J. Taylor, and A. B. Vojtek. 2003. Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex. J. Biol. Chem. 278: 47922-47927. (Pubitemid 37523241)
58. Woodgett, J. R. 1990. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9: 2431-2438.
59. Doble, B. W., and J. R. Woodgett. 2003. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116: 1175-1186. (Pubitemid 36410657)
60. Sutherland, C., I. A. Leighton, and P. Cohen. 1993. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296: 15-19. (Pubitemid 23344723)
61. Gonzalez, G. A., and M. R. Montminy. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680. (Pubitemid 19282874)
62. Habener, J. F., C. P. Miller, and M. Vallejo. 1995. cAMP-dependent regulation of gene transcription by cAMP response element-binding protein and cAMP response element modulator. Vitam. Horm. 51: 1-57.